Search Results

June 2022 "We’re delighted to welcome Dr Ed Brennan as our new Vice President, Head of Clinical Development Dr Brennan has extensive experience across all phases of clinical development, and across multiple therapeutic

GPCR contributor article Canonical chemokine receptors as scavenging “decoys” Shivani Sachdev, Brendan

Ep 120 with Brendan Wilkins Dr. GPCR Podcast << Back to podcast list Brendan Wilkins About Brendan Wilkins "Brendan completed his undergraduate In his Honours year, Brendan explored small molecule allosteric modulators of the β2-adrenoceptor under Brendan’s PhD project focuses on the orphan GPCR GPR146. Brendan is currently looking for post-doctoral positions to begin in mid-2024" Brendan Wilkins on the

University of Sydney (opioids and sensory neurons), Vollum Institute Portland (visiting scientist with Ed